Hormonal
GLP-1 agonists (e.g., semaglutide) and abstinence-based dietary interventions (Bright Line Eating) are the most effective non-surgical weight loss methods because they directly target the neurological addiction to ultra-processed foods.
If you struggle with food addiction, standard dieting will likely fail. Consider treatments that address the biological addiction, such as GLP-1 agonists or strict abstinence-based programs like Bright Line Eating, which have shown higher sustained success rates by targeting the root neurological drivers.
Interestingly, the two current weight loss approaches that most directly target addiction, GLP-1 weight loss drugs and Bright Line Eating, are the two non-surgical approaches with the highest rates of sustained weight loss.
Why this rating
The paper states research is 'nascent' and relies on observational comparisons or specific program data rather than large-scale head-to-head RCTs in this text.
Source
The Badly Behaving Brain: How Ultra-Processed Food Addiction Thwarts Sustained Weight Loss
Susan Peirce Thompson et al. · IntechOpen eBooks · 2024
DOI 10.5772/intechopen.1004428
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →